PATENT ELIGIBILITY IN AMERICA
Committee on the Judiciary: Subcommittee on Intellectual Property
concluded a hearing to examine the state of patent eligibility in
America, after receiving testimony from:
Manny Schecter, International
Business Machines Corporation, Armonk, New York;
Laurie C. Self, Qualcomm, Inc., Kimberly Chotkowski, InterDigital, and Corey Salsberg, Novartis, all of Washington, D.C.;
Byron R. Holz, Nokia, Snellville, Georgia;
Sean Reilly, The Clearing House Payments Company LLC, Gonzalo Merino, Regeneron Pharmaceuticals, and Nicolas Dupont, Cyborg Inc., all of New York, New York;
Laurie Hill, Genentech, Inc., and Sean George,
Invitae Corporation, both of San Francisco, California;
Peter O'Neill,
Cleveland Clinic Innovations, Cleveland, Ohio;
David Spetzler, Caris
Life Sciences, Irving, Texas;
Michael Blankstein, Scientific Games, Las
Vegas, Nevada;
Robert Deberardine, Johnson and Johnson, New Brunswick,
New Jersey;
and John D. Vandenberg, Klarquist Sparkman, LLP, Sherwood,
Oregon.